The same fixed-cost problem described in "Why Cases Get Rejected" creates a specific, well-defined gap in the market. Most institutional funders, including the largest names in the industry, set effective minimums somewhere between $1 million and $5 million in expected net recovery, because the cost of proper underwriting, independent legal experts, outcome modeling, diligence on counsel and collectability, is largely fixed regardless of claim size. A claim seeking $400,000 in damages costs a funder nearly as much to diligence as one seeking $4 million, which makes the smaller claim uneconomical for most of the market even when the underlying case is just as strong.
A smaller set of funders is built specifically around this range instead of treating it as a rounding error. LexShares operates both a dedicated fund and an online funding marketplace and will consider investments from roughly $200,000; Legalist focuses exclusively on mid-market matters requiring under $1 million and manages over $110 million in assets doing exactly that; Statera Capital was built specifically to serve the U.S. commercial middle market across contract, tort, IP, and other claim types. These firms are not simply smaller versions of Burford or Omni Bridgeway, they are underwriting shops purpose-built around lower fixed diligence costs and faster decision cycles.
The tradeoff claimants should expect at this size is economic, not qualitative: because fixed costs represent a larger share of a smaller recovery, middle-market funding agreements often carry a higher effective percentage or multiple than a $10 million-plus matter might command, even when the underlying legal merits are comparably strong. For a claimant genuinely priced out of the market entirely otherwise, that tradeoff, some capital on somewhat less favorable terms, versus no institutional capital at all, is usually a straightforward one.